Family Medicine Doctors in Rancho Viejo, TX Accepting Medicare
1 Family Medicine doctors found. Showing 1 - 1
 Dario Cubides, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 809 Tesoro Ave Ste E, Rancho Viejo, TX 78575 Phone: 713-647-2447 |
News Archive
Rotech commences $283.5 million registered exchange offer
Rotech Healthcare Inc., one of the largest providers of home medical equipment and related products and services, announced today that it has commenced a registered exchange offer to exchange up to $283.5 million aggregate principal amount of its Senior Second Lien Notes due 2018 which have been registered under the Securities Act of 1933, as amended for an equal principal amount of its outstanding Senior Second Lien Notes due 2018, which were issued in a private placement.
Mayo Medical Laboratories and NDSC collaborate to develop new patient blood-management solution
Mayo Clinic implemented a patient blood-management program in 2010 on its Rochester campus and has since experienced a 35-percent reduction of blood transfusions, improving patient outcomes and achieving significant savings.
Synthetic Biologics doses first patient in SYN-004 Phase 1b trial to prevent C. difficile infection
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced that enrollment has initiated and the first patient was dosed in a Phase 1b clinical trial of SYN-004, an investigational oral beta-lactamase enzyme for the prevention of Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
NICE decides not to recommend lapatinib for women with advanced breast cancer
The National Institute for Health and Clinical Excellence has decided not to recommend the oral drug lapatinib (Tyverb) for women with advanced breast cancer, except for use in clinical trials.
FDA approves Onglyza (saxagliptin) for type 2 diabetes
The U.S. Food and Drug Administration has approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults. The medication is intended to be used with diet and exercise to control high blood sugar levels.
› Verified 8 days ago